Immediate Impact
29 standout
Citing Papers
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
2023 Standout
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
2023 Standout
Works of Jesse Shustik being referenced
Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)
2014
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jesse Shustik | 77 | 23 | 24 | 110 | 48 | 11 | 137 | |
| Jasmin Lisfeld | 81 | 9 | 24 | 172 | 38 | 12 | 218 | |
| Henriette W Berenschot | 99 | 19 | 16 | 121 | 59 | 11 | 156 | |
| Maria Moschogiannis | 65 | 10 | 10 | 128 | 79 | 14 | 164 | |
| Barbara Mantoan | 71 | 36 | 28 | 103 | 53 | 13 | 152 | |
| Matthias Hänel | 57 | 56 | 16 | 105 | 77 | 7 | 183 | |
| Chiara Lobetti‐Bodoni | 103 | 8 | 10 | 154 | 70 | 11 | 184 | |
| Michela Ansuinelli | 60 | 26 | 18 | 87 | 24 | 13 | 135 | |
| Elisa Cupelli | 52 | 7 | 27 | 68 | 14 | 9 | 137 | |
| Christina Howlett | 93 | 15 | 13 | 140 | 68 | 11 | 166 | |
| Patricia Glynn | 74 | 17 | 32 | 101 | 47 | 10 | 144 |
All Works
Loading papers...